Steve Miller, PhD

Biography

Steve is the EVP, Chief Operating Officer, and Chief Scientific Officer of Catalyst. Steve joined Catalyst in 2007, just 5 years into the company’s history, to manage the in-licensing of CPP-109, CPP-115, and then Firdapse, the company’s first approved product. In his 25-year career prior to Catalyst, Steve worked in chemistry and manufacturing controls, quality systems and validation, contract operations, and development planning. Steve was drawn to Catalyst for the opportunity to identify, develop, and commercialize new products and products that could expand their indications through additional preclinical and clinical development studies.

“My catalyst is to utilize my 30 years of drug development and commercialization experience to help patients with rare diseases.”

Other Notable Roles:
Executive Director, R&D Operations, Watson Pharmaceuticals
VP, Research and Product Development, Royce Laboratories
Analytical Chemist, US Food and Drug Administration

Board Participation:
Bachelor of Science, Chemistry, University of Maryland
PhD, Physical Organic Chemistry, University of Miami

Degrees:
Journal of Analytical Chemistry
Journal of the American Chemical Society
Journal of Medical Chemistry
Chemical Communications